Relief Therapeutics Holding AG (RLFTF)

[Veritas]

I'm not gonna try to get into the FDA's head, but "safe and may be effective" seems like an especially low hurdle. As I understand it, the bigger the gap in efficacy between the treatment arm and SOC, the smaller the sample size needed. And there's a BIG gap between 80% and 17%. Not to mention, patients were followed for 60 days, which seems to be FDA's preference (at least with vaccine trials).